Tapentadol Tablet, Film Coated
Product Images NDC 0054-0945

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tapentadol (NDC 0054-0945). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tapentadol 01)

Not available.*

FDA Label Image

Figure 1 (Tapentadol 02)

This document provides information on different doses of Tapentadol and a placebo, along with a scale indicating the percentage improvement in pain from baseline at Hour 48. The doses in milligrams mentioned are: 50, 79, and 100.*

FDA Label Image

Figure 2 (Tapentadol 03)

This text appears to include information related to patient improvement percentages and pain relief measurements for a certain medication (Tiadol 501) at the specified dose of 75mg. The table shows the percentage of patients improved and the percent of improvement in pain from baseline at day 5. It seems to indicate varying levels of pain relief experienced by patients at different thresholds of improvement.*

FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (75 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.